Series: David Sackett – A Year Later
Evidence-based medicine has been hijacked: a report to David Sackett

https://doi.org/10.1016/j.jclinepi.2016.02.012Get rights and content

Abstract

This is a confession building on a conversation with David Sackett in 2004 when I shared with him some personal adventures in evidence-based medicine (EBM), the movement that he had spearheaded. The narrative is expanded with what ensued in the subsequent 12 years. EBM has become far more recognized and adopted in many places, but not everywhere, for example, it never acquired much influence in the USA. As EBM became more influential, it was also hijacked to serve agendas different from what it originally aimed for. Influential randomized trials are largely done by and for the benefit of the industry. Meta-analyses and guidelines have become a factory, mostly also serving vested interests. National and federal research funds are funneled almost exclusively to research with little relevance to health outcomes. We have supported the growth of principal investigators who excel primarily as managers absorbing more money. Diagnosis and prognosis research and efforts to individualize treatment have fueled recurrent spurious promises. Risk factor epidemiology has excelled in salami-sliced data-dredged articles with gift authorship and has become adept to dictating policy from spurious evidence. Under market pressure, clinical medicine has been transformed to finance-based medicine. In many places, medicine and health care are wasting societal resources and becoming a threat to human well-being. Science denialism and quacks are also flourishing and leading more people astray in their life choices, including health. EBM still remains an unmet goal, worthy to be attained.

References (41)

  • David L. Sackett: interview in 2014-2015. Available at...
  • Evidence-based medicine. A new approach to teaching the practice of medicine

    JAMA

    (1992)
  • A.D. Oxman et al.

    Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group

    JAMA

    (1993)
  • I.A. Giannakakis et al.

    Arabian nights-1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report

    BMJ

    (2000)
  • T. Greenhalgh et al.

    Evidence based medicine: a movement in crisis?

    BMJ

    (2014)
  • T. Greenhalgh

    Why do we always end up here? Evidence-based medicine's conceptual cul-de-sacs and some off-road alternative routes

    J Prim Health Care

    (2012)
  • N.A. Khan et al.

    Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis

    Arthritis Rheum

    (2012)
  • M.L. Anderson et al.

    Compliance with results reporting at ClinicalTrials.gov

    N Engl J Med

    (2015)
  • S. Every-Palmer et al.

    How evidence-based medicine is failing due to biased trials and selective publication

    J Eval Clin Pract

    (2014)
  • E.H. Turner et al.

    Selective publication of antidepressant trials and its influence on apparent efficacy

    N Engl J Med

    (2008)
  • Cited by (0)

    View full text